Source link : https://www.newshealth.biz/health-news/tnf-inhibitors-may-cut-heart-risk-in-ankylosing-spondylitis/
TOPLINE: Patients with ankylosing spondylitis who were exposed to tumor necrosis factor (TNF) inhibitors had an approximately 30% lower risk for cardiovascular events than those who had never been exposed to any biologic disease-modifying antirheumatic drugs (bDMARDs). METHODOLOGY: The researchers conducted a nationwide population-based cohort study to assess the effects of TNF and interleukin-17 (IL-17) […]
Author : News Health
Publish date : 2024-12-06 09:49:00
Copyright for syndicated content belongs to the linked Source.